Nanoscope Technologies is a biotechnology startup founded in 2009 with a mission to develop innovative methods and devices for scientific, industrial, and biomedical applications. The company's range of biomedical technologies includes diagnostics and therapeutic devices and molecules, which have garnered attention from clinicians, industries, and leaders. Nanoscope Technologies is focused on translating its technology to the market and bedside. The startup received a grant investment on 28 May 2020 from the National Institutes of Health, reflecting the interest and support from prominent backers in the industry. With a focus on biotechnology, health care, information technology, and manufacturing, Nanoscope Technologies stands at the forefront of cutting-edge innovation and advancement within multiple sectors. Its slogan, "Seeing the unseen," encapsulates the company's commitment to pushing boundaries and making significant contributions to the fields it operates in.
Funding Stage | Amount | No. Investors | Investors | Date |
---|---|---|---|---|
Grant | Unknown | 1 | National Institutes of Health | 28 May 2020 |
Grant | $4.00M | 1 | National Institutes of Health | 21 Sep 2018 |
No recent news or press coverage available for Nanoscope Technologies.